Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial Academic Article uri icon

Overview

MeSH Major

  • Granulomatosis with Polyangiitis
  • Immunoglobulin G
  • Neoplasms
  • Tumor Necrosis Factor-alpha

abstract

  • Data from the WGET, the first substantial reported experience of the combined use of etanercept and cyclophosphamide in the treatment of WG, indicate that the combination of TNF inhibition and cyclophosphamide may heighten the risk of cancer beyond that observed with cyclophosphamide alone.

publication date

  • May 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/art.21869

PubMed ID

  • 16646004

Additional Document Info

start page

  • 1608

end page

  • 18

volume

  • 54

number

  • 5